FrancophonIA/ELRC3.0 huggingface dataset:
English: 6, rue de la Rochefoucauld 16000 Angoulême France
Danish: AJC INVEST 6, rue de la Rochefoucauld 16000 Angoulême France
English: Rua Quinta do PinheiroEdifício Tejo - 6º Piso 2790-143 Carnaxide Portugal
Danish: Quinta do PinheiroEdifício Tejo - 6º Piso 2790-143 Carnaxide Portugal
English: 140 00 Praha Czech Republic
Danish: 140 00 Praha
English: 1 cours du Triangle 9296 Paris la Défense Cedex
Danish: 1 cours du Triangle 9296 Paris la Défense Cedex France
English: SANOFI AVENTIS FRANCE 1-13, boulevard Romain Rolland
Danish: 1-13, boulevard Romain Rolland
English: SERVIER HELLAS PHARMACEUTICALS Ltd, Ethnikis Antistaseos 72 & Agamemnonos Greece
Danish: Ethnikis Antistaseos 72 & Agamemnonos Greece
English: Jaba Recordati, S. A. Lagoas Park, Edificio 5, Torre C, Piso 3 2740298 Porto Salvo Portugal
Danish: Jaba Recordati, S. A. Lagoas Park, Edificio 5, Torre C, Piso 3 2740-298 Porto Salvo
English: Vida - Produtos Farmacêuticos, S.A. Rua da Estação, 42 - Vala do Carregado 2600-726 Castanheira do Ribatejo
Danish: Rua da Estação, 42 - Vala do Carregado
English: Valaoritou 10
Danish: HELP ABEE, Valaoritou 10
English: CLL PHARMA Nice Premier - Arénas 455, Promenade des Anglais
Danish: CLL PHARMA Nice Premier - Arénas 455, Promenade des Anglais 06299 Nice Cedex 03 France
English: Controlled release tablet Oral use
Danish: Filmovertrukket tablet med modificeret udløsning Oral anvendelse
English: Trimetazidina Mepha LP
Danish: Trimetazidina Mepha LP 35 mg
English: Teva Pharma B.V. Computerweg 10
Danish: Computerweg 10
English: Trimetazidine Actavis 35 mg ilgstošās darbības tabletes 35 mg
Danish: Trimetazidine Actavis 35 mg ilgstošās darbības tabletes
English: Poland ratiopharm GmbH Graf-Arco-Strasse 3 Ulm, 89079
Danish: Polen ratiopharm GmbH Graf-Arco-Strasse 3 Ulm, 89079
English: Trimetazidine Teva 35 mg ilgstošās darbības tabletes 35 mg
Danish: Trimetazidine Teva 35 mg ilgstošās darbības tabletes
English: Trimetazidina Mepha 20 mg Comprimidos Revestidos 20 mg
Danish: Trimetazidina Mepha 20 mg Comprimidos Revestidos
English: Bulgaria ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Danish: Bulgarien ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
English: Hungary ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Danish: Ungarn ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
English: Trimetazidina Generis 20 mg Comprimidos Revestidos 20 mg
Danish: Trimetazidina Generis 20 mg Comprimidos Revestidos
English: Slovak Republic ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Danish: Slovakiet ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
English: TRIMETAZIDINE BIOGARAN 35 mg
Danish: TRIMETAZIDINE BGR 35 mg
English: TRIMETAZIDINE MILGEN 20 mg
Danish: TRIMETAZIDINE TEVA 20 mg
English: TRIMETAZIDINE MILGEN 20 mg/ml
Danish: TRIMETAZIDINE TEVA 20 mg/ml
English: TRIMETAZIDINE BGR
Danish: TRIMETAZIDINE BIOGARAN
English: 1 February 2016 EMA/492394/2015 Corr. 1
Danish: Den 20. oktober 2015 EMA/828131/2015
English: Very rarely, allergic reactions, sometimes severe, have been reported.
Danish: I meget sjældne tilfælde er beskrevet allergiske reaktioner, undertiden alvorlige.
English: Linseed
Danish: Hørfrø
English: Linseed should only be used in adults and adolescent aged over 12 years.
Danish: Hørfrø bør kun anvendes hos voksne og unge over 12 år.
English: What is linseed?
Danish: Hvad er hørfrø?
English: This effect may reduce gastrointestinal discomfort.
Danish: Denne virkning kan mindske mave-tarm-ubehag.
English: Other information about linseed medicines
Danish: Andre oplysninger om lægemidler, der indeholder hørfrø
English: It is likely that linseed mucilage coats the lining of the digestive tract and thus protects it from irritation.
Danish: Det er sandsynligt, at hørfrøenes slimlag dækker fordøjelseskanalens overflade og derfor beskytter den mod irritation.
English: This means that there are bibliographic data providing scientific evidence of linseed's effectiveness and safety when used in this way, covering a period of at least 10 years in the EU.
Danish: Det betyder, at der foreligger bibliografiske data, der danner videnskabelig dokumentation for hørfrøs sikkerhed og virkning, når de anvendes på denne måde, og som dækker en periode på mindst 10 år i EU.
English: Linseed is the common name for the seeds of the plant Linum usitatissimum L. The dried, ripe seeds for medicinal use are obtained from plants that have been cultivated.
Danish: Hørfrø er fællesnavnet for frø af planten Linum usitatissimum L. De tørrede modne frø til medicinsk anvendelse fås fra dyrkede planter.
English: Linseed can also be found in combination with other herbal substances in some herbal medicines.
Danish: Hørfrø findes desuden kombineret med andre droger i visse plantelægemidler.
English: Any applications for the licensing of medicines containing linseed have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Danish: Ansøgninger om godkendelse af lægemidler, der indeholder hørfrø, skal indsendes til de nationale lægemiddelmyndigheder, som vurderer ansøgningen om plantelægemidlet og tager hensyn til HMPC's videnskabelige konklusioner.
English: Information on the use and licensing of linseed medicines in EU Member States should be obtained from the relevant national authorities.
Danish: Oplysninger om europæisk anvendelse og godkendelse af lægemidler, der indeholder hørfrø, skal indhentes fra de relevante nationale myndigheder i EU's medlemsstater.
English: Herbal medicines containing linseed, also known as Lini semen, are to be taken by mouth.
Danish: Plantelægemidler med hørfrø, der også kaldes Lini semen, skal indtages gennem munden.
English: These include bulging of the belly.
Danish: Hertil hører opsvulmet mave.
English: How are linseed medicines approved in the EU?
Danish: Hvordan godkendes lægemidler, der indeholder hørfrø, i EU?
English: The HMPC concluded that linseed can be used to treat habitual constipation or in conditions requiring the stool to be softer so it can pass more easily.
Danish: HMPC har konkluderet, at hørfrø kan anvendes til behandling af vedvarende forstoppelse eller tilstande, der kræver, at afføringen gøres blødere, så den passerer lettere.
English: Common side effects (seen between 1 and 10 patients in 100) have been reported with linseed.
Danish: Ved brug af lægemidler med hørfrø er beskrevet almindelige bivirkninger (der optræder hos mellem 1 og 10 patienter ud af 100).
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing linseed.
Danish: EU's medlemsstater tager hensyn til HMPC's konklusioner, når de vurderer ansøgninger om godkendelse af plantelægemidler, der indeholder hørfrø.
English: Further information on the risks associated with linseed medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Danish: Yderligere oplysninger om risici forbundet med lægemidler, der indeholder hørfrø, herunder passende forholdsregler, som skal følges med henblik på sikker anvendelse, findes i monografien under fanebladet "All documents" på Det Europæiske Lægemiddelagenturs websted: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: Detailed instructions on how to take linseed medicines and who can use them can be found in the package leaflet that comes with the medicine.
Danish: Detaljerede anvisninger for, hvordan lægemidler med hørfrø skal anvendes, og hvem der må bruge dem, findes i indlægssedlen i lægemiddelpakningen.
English: Further information on the HMPC assessment of linseed medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Danish: Yderligere oplysninger om HMPC's vurdering af lægemidler, der indeholder hørfrø, herunder detaljerede oplysninger om udvalgets konklusioner, findes under "All documents" på Det Europæiske Lægemiddelagenturs websted: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: How does linseed work as a medicine?
Danish: Hvordan virker hørfrø som lægemiddel?
English: This summary is not intended to provide practical advice on how to use medicines containing linseed.
Danish: Dette sammendrag er ikke en praktisk vejledning i, hvordan plantelægemidler, der indeholder hørfrø, anvendes.
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of linseed.
Danish: Dette er et sammendrag af Komiteen for Plantelægemidlers (HMPC) videnskabelige konklusioner angående den medicinske anvendelse af hørfrø.
English: Although an early clinical study on linseed for the treatment of gastrointestinal discomfort is available, it was too limited to be used them as evidence and the HMPC's conclusions for this indication are based on the medicines' long-standing use.
Danish: Skønt der foreligger en ældre klinisk undersøgelse af hørfrø til behandling af mave-tarm-ubehag, var den for begrænset som dokumentation, og HMPC's konklusioner vedrørende denne anvendelse er derimod baseret på lægemidlernes mangeårige brug til ovenstående formål.
English: Also, the swelling effect of linseed widens the gut and this stretching effect speeds up passage of the stool through the gut.
Danish: Den opsvulmende virkning af hørfrø udvider desuden tarmen, og denne strækkende virkning fremmer afføringens passage gennem tarmen.
English: For detailed information on the studies assessed by the HMPC, see the HMPC assessment report.
Danish: Nærmere oplysninger om de undersøgelser/informationer, der indgår i HMPC's vurdering, findes i HMPC's vurderingsrapport.
English: In its assessment, the HMPC considered a number of clinical studies showing linseed's effect on constipation and hard stool.
Danish: I HMPC's vurdering indgik en række kliniske undersøgelser, der viser virkningen af hørfrø på forstoppelse og hård afføring.
English: The studies demonstrated that linseed reduced habitual constipation.
Danish: Undersøgelserne viste, at hørfrø mindskede vedvarende forstoppelse.
English: Linseed must not be used in patients who have difficulty swallowing or have any throat problems.
Danish: Hørfrø må ikke anvendes til patienter med synkebesvær eller problemer i svælget.
English: What are the risks associated with linseed medicines?
Danish: Hvilke risici er der forbundet med lægemidler, der indeholder hørfrø?
English: For treating constipation, linseed must not be used in patients with a sudden change in bowel habit that persists for more than 2 weeks, or undiagnosed bleeding from the anus, or if constipation is not relieved despite the use of a laxative.
Danish: Til behandling af forstoppelse må hørfrø ikke anvendes hos patienter med pludselige ændringer i afføringsmønsteret, der varer længere end 2 uger.Hørfrø må heller ikke anvendes ved udiagnosticeret blødning fra endetarmen, eller hvis forstoppelsen ikke aftager trods brug af et afføringsmiddel.
English: The HMPC conclusions on the use of linseed for treating constipation are based on ‘well-established use'.
Danish: HMPC's konklusioner om anvendelsen af lægemidler med hørfrø til behandling af forstoppelse er baseret på den "almindelig anerkendte anvendelse".
English: This helps to make the stool softer and pass through the gut more easily.
Danish: Dette gør afføringen blødere, så den lettere passerer gennem tarmen.
English: What evidence supports the use of linseed medicines?
Danish: Hvilken dokumentation underbygger den medicinske anvendelse af hørfrø?
English: It should also not be used in patients with abnormal constriction or blockage of the digestive tract, paralysis in the gut, or abnormal widening of the large intestine, or with diseases of the oesophagus (the tube between mouth and stomach).
Danish: Det må heller ikke anvendes hos patienter med abnorm forsnævring eller blokering af mave-tarmkanalen, tarmslyng eller abnormt udspilet tyktarm, eller med sygdomme i spiserøret.
English: For more information about treatment with linseed medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med lægemidler, der indeholder hørfrø, kan du læse indlægssedlen, der ligger i lægemiddelpakningen, eller kontakte din læge eller dit apotek.
English: For practical information about using linseed medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Danish: Hvis du ønsker praktiske oplysninger om anvendelsen af lægemidler med hørfrø, kan du læse indlægssedlen, der ligger i lægemiddelpakningen, eller kontakte din læge eller dit apotek.
English: Linseed swells with water in the gut to form a thick jelly-like substance (mucilage).
Danish: Hørfrø svulmer op i tarmen og danner sammen med vand en tyk, geleagtig slim.
English: Advice should be taken from a doctor or a qualified healthcare professional if constipation persists after 3 days of using linseed or if mild gastrointestinal discomfort persists after 7 days of using linseed.
Danish: Hvis forstoppelsen vedvarer efter 3 dages brug af hørfrø, eller hvis der stadig er let mave-tarm-ubehag efter 7 dages brug af hørfrø, bør der søges råd hos en læge eller på apoteket.
English: The HMPC also concluded that, on the basis of its long-standing use, linseed can be used to relieve mild gastrointestinal (stomach and gut) discomfort.
Danish: På baggrund af den mangeårige anvendelse har HMPC desuden konkluderet, at hørfrø kan anvendes til lindring af let mave-tarm-ubehag.
English: The HMPC conclusions on the use of linseed medicines for the relief of mild gastrointestinal discomfort are based on their ‘traditional use' in this condition.
Danish: HMPC's konklusioner vedrørende brugen af lægemidler med hørfrø er baseret på lægemidlernes "traditionelle anvendelse" til let mave-tarm-ubehag.
English: Zona Industrial da Abrunheira Edifício 10 - Sintra Business Park 2710-089 Sintra Portugal
Danish: Zona Industrial da Abrunheira Edifício 10 - Sintra Business Park 2710-089 Sintra
English: Baxter MédicoFarmacêutica, Lda.
Danish: Baxter Médico-Farmacêutica, Lda.
English: Czech Republic BAXTER CZECH spol.
Danish: BAXTER CZECH spol.
English: Pouet de Camilo, 2 46394 Ribarroja del Turia (Valencia) Spain
Danish: 46394 Ribarroja del Turia (Valencia) Spain
English: Belgium BAXTER S.A. Bd. René Branquart 80 7860 Lessines
Danish: Bd. René Branquart 80 7860 Lessines Belgium
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states for Numeta G13%E and Numeta G16%E emulsions for infusion
Danish: Bilag I Fortegnelse over lægemidlernes navne, lægemiddelform(er), styrke(r), indgivelsesvej(e), indehaver(e) af markedsføringstilladelse(r) i medlemsstaterne
English: Baxter Deutschland GmbH
Danish: Baxter Deutschland GmbH Edisonstr.
English: Poligono Industrial Sector 14
Danish: Poligono Industrial Sector 14 Pouet de Camilo, 2
English: 00144 ROMA Italy
Danish: Piazzale dell' Industria, 20 00144 ROMA
English: Numeta G 16 % E Emulsion zur Infusio
Danish: Numeta G 16 % E Emulsion zur Infusion
English: MUMETA G16%E, emulsión para perfusión
Danish: NUMETA G16%E, emulsión para perfusión
English: MUMETA G13%E, emulsión para perfusión
Danish: NUMETA G13%E, emulsión para perfusión
English: NUMETA (G16)
Danish: NUMETZAH G16%E
English: 16 May 2013
Danish: Den 16. maj 2013
English: The decentralised procedure (DE/V/0122/002/DC) started on 12 November 2010.
Danish: Den decentrale procedure (DE/V/0122/002/DC) blev indledt den 12. november 2010.
English: Therefore the CVMP recommended the refusal of the granting of the marketing authorisations and the suspension of the existing marketing authorisations.
Danish: CHMP anbefalede derfor afslag på ansøgningen om udstedelse af markedsføringstilladelse og suspendering af de eksisterende markedsføringstilladelser.
English: Day 60 of the CMD(v) procedure was on 15 December 2011, and since the Member States concerned failed to reach an agreement regarding the product the procedure was referred to the CVMP.
Danish: Dag 60 af proceduren i CMD(v) var den 15. december 2011, og da de berørte medlemsstater ikke var i stand til at nå til enighed vedrørende produktet, blev proceduren indbragt for CVMP.
English: On 31 August 2012, the Netherlands submitted an objection to the opinion adopted by CVMP on 13 June 2012 during the written phase of the Standing Committee procedure.
Danish: Den 31. august 2012 indgav Nederlandene en indsigelse mod CVMP's udtalelse, som var vedtaget den 13. juni 2012 under den skriftlige fase af behandlingen i det stående udvalg.
English: The reconsidered opinion was converted into a Decision by the European Commission on 16 May 2013.
Danish: Den 16. maj 2013 blev den fornyede udtalelse omarbejdet til en beslutning truffet af EuropaKommissionen.
English: On 27 September 2012 a plenary meeting of the Standing Committee on Veterinary Medicinal Products took place and on 3 October 2012 the European Commission sent a letter to the CVMP requesting a reconsideration of the opinion adopted on 13 June 2012.
Danish: Den 27. september 2012 afholdtes plenarmøde i Det Stående Udvalg for Veterinærlægemidler, og den 3. oktober 2012 anmodede Europa-Kommissionen skriftligt CVMP om fornyet overvejelse af den udtalelse, der var vedtaget den 13. juni 2012.
English: On 7 February 2013 the CVMP adopted a reconsidered opinion, concluding that the application does not comply with Article 13 of Directive 2001/82/EC, and consequently does not satisfy the criteria for authorisation in respect of efficacy.
Danish: Den 7. februar 2013 vedtog CVMP en fornyet udtalelse, hvori det konkluderedes, at ansøgningen ikke opfylder bestemmelserne i artikel 13 i direktiv 2000/82/EF og således ikke opfylder godkendelseskriterierne hvad angår virkning.
English: Potential serious risks were identified during the decentralised procedure by Denmark regarding the cumulative failure rate observed in the pivotal clinical field trial and potential for development of antimicrobial resistance to florfenicol.
Danish: Under den decentrale procedure blev der af Danmark påpeget potentielle alvorlige risici som følge af høj andel af kumulative behandlingssvigt i den kliniske hovedfeltundersøgelse og potentiale for udvikling af antimikrobiel resistens over for florfenicol.
English: The proposed dose is 30 mg florfenicol per kg bodyweight given by intramuscular administration as a single injection.
Danish: Den ansøgte dosis er 30 mg florfenicol/kg kropsvægt, givet som en enkelt intramuskulær injektion.
English: Written explanations were provided by the applicant on 20 March 2012.
Danish: Ansøgeren fremsendte skriftlige redegørelser den 20. marts 2012.
English: On 19 December 2011, the reference Member State, Germany, notified to the European Medicines Agency that the CMD(v) had failed to reach an agreement regarding the product and referred the matter to the CVMP pursuant to Article 33(4) of Directive 2001/82/EC.
Danish: Den 19. december 2011 underrettede referencemedlemsstaten, Tyskland, Det Europæiske Lægemiddelagentur om, at CMD(v) ikke havde været i stand til at nå til enighed vedrørende produktet, og indbragte sagen for CVMP i henhold til artikel 33, stk. 4, i direktiv 2001/82/EF.
English: The list of product names concerned is given in Annex I. The scientific conclusions are provided in Annex II, together with the condition to lift the suspension of the marketing authorisation in Annex III.
Danish: Listen over de berørte produktnavne fremgår af bilag I. De videnskabelige konklusioner fremgår af bilag II.
English: The reconsideration procedure started on 10 October 2012.
Danish: Den fornyede overvejelsesprocedure blev indledt den 10. oktober 2012.
English: This was a ‘hybrid application' according to Article 13(3) Directive 2001/82/EC, as amended, referring to the reference product, Nuflor Swine 300 mg/ml solution for injection (FR/V/0118/001).
Danish: Ansøgningen er en “hybrid ansøgning” (i henhold til artikel 13, stk. 3, i direktiv 2001/82/EF, som ændret), idet ansøgningen henviser til et referenceprodukt, Nuflor Swine, injektionsvæske, opløsning, 300 mg/ml (FR/V/0118/001).
English: Nuflor Swine Once 450 mg per ml solution for injection contains florfenicol as active ingredient and is intended for use in pigs for the treatment of respiratory infections caused by strains of Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida susceptible to florfenicol.
Danish: Nuflor Swine Once, injektionsvæske, opløsning, 450 mg/ml, indeholder florfenicol som aktivt indholdsstof og er bestemt til anvendelse hos svin til behandling af luftvejsinfektioner forårsaget af florfenicolfølsomme stammer af Actinobacillus pleuropneumoniae, Haemophilus parasuis og Pasteurella multocida.
English: Oral explanations were given by the applicant on 10 January 2013.
Danish: Ansøgeren afgav mundtlige redegørelser den 10. januar 2013.
English: Based on the evaluation of the available data, the CVMP adopted, on 13 June 2012, an opinion recommending the granting of marketing authorisations for Nuflor Swine Once 450 mg/ml solution for injection, subject to certain conditions.
Danish: På grundlag af vurderingen af de foreliggende data afgav CVMP den 13. juni 2012 en udtalelse, som anbefalede udstedelse af markedsføringstilladelse for Nuflor Swine Once, injektionsvæske, opløsning, 450 mg/ml, på visse betingelser.
English: The referral procedure started on 10 January 2012.
Danish: Indbringelsesproceduren blev indledt den 10. januar 2012.
English: On day 210, these issues remained unsolved and therefore a referral under Article 33(1) of Directive 2001/82/EC to the Coordination group for Mutual recognition and Decentralised procedures
Danish: På dag 210 var disse spørgsmål fortsat uafklarede, hvorfor sagen den 17. oktober 2011 i henhold til artikel 33, stk. 1, i direktiv 2001/82/EF blev indbragt for koordinationsgruppen vedrørende gensidig anerkendelse og decentrale godkendelsesprocedurer - veterinær (CMD(v)).
English: The Committee re-appointed Prof Christian Friis as rapporteur and Dr Cornelia Ibrahim as co-rapporteur for the reconsideration procedure.
Danish: Som rapportør og medrapportør genudpegede udvalget henholdsvis prof. Christian Friis og dr. Cornelia Ibrahim.
English: The applicant, Intervet International BV, submitted an application for a decentralised procedure for Nuflor Swine Once 450 mg/ml solution for injection.
Danish: Ansøgeren, Intervet International BV, har indgivet en ansøgning via den decentrale procedure for Nuflor Swine Once, injektionsvæske, opløsning, 450 mg/ml.
English: Opinion following an Article 33(4)1 referral for Nuflor Swine Once 450 mg/ml solution for injection
Danish: Udtalelse efter en indbringelse i henhold til artikel 33, stk. 4,1 for Nuflor Swine Once, injektionsvæske, opløsning, 450 mg/ml
English: Opinion following an Article 33(4)0F referral for Nuflor Swine Once 450 mg/ml solution for injection
Danish: Udtalelse efter en indbringelse i henhold til artikel 33, stk. 4,0F for Nuflor Swine Once, injektionsvæske, opløsning, 450 mg/ml
English: You may need one or two infusions.
Danish: Du kan have behov for én eller to infusioner.
English: 12-16 hours
Danish: 12-16 timer
English: Date of first authorisation: 23 November 2007 Date of latest renewal: 20 July 2012
Danish: Dato for første markedsføringstilladelse: 23. november 2007 Dato for seneste fornyelse: 20. juli 2012
English: If these temporary conditions have been exceeded, the product should be discarded.
Danish: Hvis disse midlertidige betingelser er blevet overskredet, skal produktet bortskaffes.
English: This red colouration has no other consequences on your body.
Danish: Denne rødfarvning har ikke andre virkninger på din krop.
English: It depends on how serious the poisoning is.
Danish: Det afhænger af, hvor alvorlig forgiftningen er.
English: 24 hours with the exception of bilirubin (up to 4 days)
Danish: 24 timer med undtagelse af bilirubin (op til 4 dage)